No interaction found

Terbutin 15 mg/50 mg/1.25 mg Liquid may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

No information is available on the use of Terbutin 15 mg/50 mg/1.25 mg Liquid during lactation. Please consult your doctor.

It is not known whether Terbutin 15 mg/50 mg/1.25 mg Liquid alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Terbutin 15 mg/50 mg/1.25 mg Liquid should be used with caution in patients with kidney disease. Dose adjustment of Terbutin 15 mg/50 mg/1.25 mg Liquid may be needed. Please consult your doctor.

Terbutin 15 mg/50 mg/1.25 mg Liquid should be used with caution in patients with liver disease. Dose adjustment of Terbutin 15 mg/50 mg/1.25 mg Liquid may be needed. Please consult your doctor.Limited information is available on the use of Terbutin 15 mg/50 mg/1.25 mg Liquid in these patients.